$TRUP

GALLAGHER JOHN R sold $78K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 3,603 shares of TRUPANION, INC. (TRUP) at $21.69 on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Jun 2, 2026, 12:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 1:02 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The disclosure provides transparency on insider activity but does not, by itself, indicate a new operational or financial development.

02

Market read

A disclosed 10b5-1 insider sale in TRUP; expected to be low-signal for fundamentals.

03

What to watch

The filing date may lag the sale date; the market reaction (if any) would depend on whether the sale was already anticipated or coincided with other news.

Relevance 6/10Novelty 3/10Timing: Filed June 1; sale executed May 28 under a 10b5-1 plan.

Background

This is an SEC Form 4 insider transaction for TRUPANION, Inc. (TRUP) by its COO, disclosed as an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUPANION COO John R Gallagher sold 3,603 shares in an open-market transaction disclosed on SEC Form 4.

Expected impact

Likely limited near-term impact; any move would be more sentiment/flow-driven than fundamental.

Evidence & confidence

Form 4 shows a scheduled 10b5-1 sale rather than an unscheduled discretionary trade, so informational content is typically lower.

Market effects

Minimal—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with internal caution; traders may still watch for follow-on selling or other insider actions.

Key entities

  • TRUPANION, INC.

    Company whose insider transaction was reported; COO John R Gallagher sold shares under a 10b5-1 plan.

  • GALLAGHER JOHN R

    Chief Operating Officer who executed the reported open-market sale.

  • Rule 10b5-1 plan

    Pre-arranged trading plan that typically lowers the informational value of the sale.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin